It comes as data shows more people are contracting drug-resistant superbugs than ever before, with antimicrobial resistance (AMR) predicted to cause 10 million global deaths each year by 2050 if no action is taken.
NHS England is building on its world-first pilot to incentivise the pharmaceutical industry to develop new antibiotics that could be offered to NHS patients when they need them the most. NHS England
No comments:
Post a Comment